Krebs Biochem

9
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
69.89
0.00 (0.00%)
BSENSE

Dec 19

BSE+NSE Vol: 1.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024

Compare Profit and Loss Results of Krebs Biochem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
43.00
116.00
-73.00
-62.93%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
43.00
116.00
-73.00
-62.93%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-8.00
11.00
137.50%
Raw Materials Consumed
2.00
60.00
-58.00
-96.67%
Power & Fuel Cost
18.00
10.00
8.00
80.00%
Employee Cost
16.00
12.00
4.00
33.33%
Operating Expenses
12.00
14.00
-2.00
-14.29%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
58.00
99.00
-41.00
-41.41%
Operating Profit (PBDIT) excl Other Income
-15.00
16.00
-31.00
-193.75%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
-14.00
18.00
-32.00
-177.78%
Interest
5.00
6.00
-1.00
-16.67%
Profit before Depriciation and Tax
-20.00
12.00
-32.00
-266.67%
Depreciation
6.00
5.00
1.00
20.00%
Profit Before Taxation & Exceptional Items
-26.00
6.00
-32.00
-533.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-26.00
6.00
-32.00
-533.33%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
-26.00
5.00
-31.00
-620.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-270.00
20.00
-290.00
-1,450.00%
Profit Available for appropriations
-297.00
25.00
-322.00
-1,288.00%
Appropriations
-297.00
25.00
-322.00
-1,288.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-12.49
4.1
-16.59
-404.63%
Profit And Loss - Net Sales
Net Sales 43.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -15.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

Profit And Loss - Interest
Interest 5.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -26.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024